![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
CABOTEGRAVIR PHARMACOKINETIC TAIL IN PREGNANCY AND NEONATAL OUTCOMES
|
|
|
CROI 2020
Reported by Jules Levin
Parul Patel1, Shanker Thiagarajah2, Susan Ford3, David A. Margolis1, Beth H. Romach1, Mark Baker4, Kenneth Sutton1, Conn M. Harrington1, Mark S. Shaefer1, W
1ViiV Healthcare, Research Triangle Park, NC, USA,2GlaxoSmithKline, Uxbridge, UK,3GlaxoSmithKline, Research Triangle Park, NC, USA,4ViiV Healthcare, Nyon, Switzerland
![0317201](../images/031720/031720-7/0317201.gif)
![0317202](../images/031720/031720-7/0317202.gif)
![0317203](../images/031720/031720-7/0317203.gif)
![0317204](../images/031720/031720-7/0317204.gif)
![0317205](../images/031720/031720-7/0317205.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|